Reply to: Clarification to provide further understanding of the conduct and design of TROPIC: A Phase 3 trial of cabazitaxel versus mitoxantrone in patients with metastatic castration-resistant prostate cancer

by Gianpaolo Perletti

Published in Archivio Italiano di Urologia e Andrologia by PAGEPress Publications.

2016 Volume 88, p74

Not available.
In application/xml+jats format

application/pdf 110.4 kB
file_jg44u5e3lndm5lh5rg67fqucxi www.pagepressjournals.org (web)
web.archive.org (webarchive)

Preserved and Accessible

Type article-journal
Stage

published

Date 2016-03-31

DOI 10.4081/aiua.2016.1.74
PubMed 27072185
Wikidata Q49058054

Container Metadata
Open Access Publication
In DOAJ
In Keepers Registry
ISSN-L: 1124-3562

Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)

Cite This

BibTeX
CSL-JSON
MLA
Harvard

Lookup Links

oaDOI/unpaywall (OA fulltext)
Crossref Metadata (via API)
Worldcat
SHERPA/RoMEO (journal policies)
wikidata.org
CORE.ac.uk
Semantic Scholar
Google Scholar

Catalog Record
Revision: 8357b68a-7622-4975-b431-0421aa18808f
API URL: JSON

Reply to: Clarification to provide further understanding of the conduct and design of TROPIC: A Phase 3 trial of cabazitaxel versus mitoxantrone in patients with metastatic castration-resistant prostate cancer release_puyexq63trfc5iqcoxzxowmlmq